Task-induced brain activity patterns in type 2 diabetes: a potential biomarker for cognitive decline

Thomas J Marder, Veronica L Flores, Nicolas R Bolo, Wouter S Hoogenboom, Donald C Simonson, Alan M Jacobson, Sarah E Foote, Martha E Shenton, Reisa A Sperling, Gail Musen, Thomas J Marder, Veronica L Flores, Nicolas R Bolo, Wouter S Hoogenboom, Donald C Simonson, Alan M Jacobson, Sarah E Foote, Martha E Shenton, Reisa A Sperling, Gail Musen

Abstract

Patients with type 2 diabetes demonstrate reduced functional connectivity within the resting state default mode network (DMN), which may signal heightened risk for cognitive decline. In other populations at risk for cognitive decline, additional magnetic resonance imaging abnormalities are evident during task performance, including impaired deactivation of the DMN and reduced activation of task-relevant regions. We investigated whether middle-aged type 2 diabetic patients show these brain activity patterns during encoding and recognition tasks. Compared with control participants, we observed both reduced 1) activation of the dorsolateral prefrontal cortex during encoding and 2) deactivation of the DMN during recognition in type 2 diabetic patients, despite normal cognition. During recognition, activation in several task-relevant regions, including the dorsolateral prefrontal cortex and DMN regions, was positively correlated with HbA1c and insulin resistance, suggesting that these important markers of glucose metabolism impact the brain's response to a cognitive challenge. Plasma glucose ≥11 mmol/L was associated with impaired deactivation of the DMN, suggesting that acute hyperglycemia contributes to brain abnormalities. Since elderly type 2 diabetic patients often demonstrate cognitive impairments, it is possible that these task-induced brain activity patterns observed in middle age may signal impending cognitive decline.

© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Figures

Figure 1
Figure 1
Regions activated (red) and deactivated (blue) during the encoding (A) and recognition (B) tasks in control subjects (CO) and type 2 diabetic patients (T2DM). Group differences between control subjects and diabetic patients and between diabetic patients with PG ≥11 mmol/L and <11 mmol/L. Age was controlled for in these analyses. See Table 2 for region lists. Statistical parametric brain activation maps within and between groups were computed using one-sample t tests for within-group and unpaired two-sample t tests for between-group analyses with a significance threshold of P < 0.05 (corrected). A z statistic threshold value of 2.3 was applied using the standard cluster-based thresholding Gaussian Random Field theory for inference provided by FSL (25).

References

    1. Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K. Central obesity and increased risk of dementia more than three decades later. Neurology 2008;71:1057–1064
    1. Reijmer YD, van den Berg E, Ruis C, Kappelle LJ, Biessels GJ. Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev 2010;26:507–519
    1. Shaffer JL, Petrella JR, Sheldon FC, et al. Alzheimer’s Disease Neuroimaging Initiative Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. Radiology 2013;266:583–591
    1. Jack CR, Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol 2010;9:119–128
    1. Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci USA 2004;101:4637–4642
    1. Celone KA, Calhoun VD, Dickerson BC, et al. Alterations in memory networks in mild cognitive impairment and Alzheimer’s disease: an independent component analysis. J Neurosci 2006;26:10222–10231
    1. Perantie DC, Wu J, Koller JM, et al. Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care 2007;30:2331–2337
    1. Musen G, Jacobson AM, Bolo NR, et al. Resting-state brain functional connectivity is altered in type 2 diabetes. Diabetes 2012;61:2375–2379
    1. Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol 2011;68:51–57
    1. Schott BH, Wüstenberg T, Wimber M, et al. The relationship between level of processing and hippocampal-cortical functional connectivity during episodic memory formation in humans. Hum Brain Mapp 2013;34:407–424
    1. Buckner RL, Petersen SE, Ojemann JG, Miezin FM, Squire LR, Raichle ME. Functional anatomical studies of explicit and implicit memory retrieval tasks. J Neurosci 1995;15:12–29
    1. van Harten B, Oosterman JM, Potter van Loon BJ, Scheltens P, Weinstein HC. Brain lesions on MRI in elderly patients with type 2 diabetes mellitus. Eur Neurol 2007;57:70–74
    1. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971;9:97–113
    1. Yonelinas AP, Hopfinger JB, Buonocore MH, Kroll NE, Baynes K. Hippocampal, parahippocampal and occipital-temporal contributions to associative and item recognition memory: an fMRI study. Neuroreport 2001;12:359–363
    1. Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 2013;9:106–118
    1. Duff K, Foster NL, Dennett K, et al. Amyloid deposition and cognition in older adults: the effects of premorbid intellect. Arch Clin Neuropsychol 2013;28:665–671
    1. Musen G, Lyoo IK, Sparks CR, et al. Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 2006;55:326–333
    1. de la Monte SM, Wands JR. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer’s disease. J Alzheimers Dis 2005;7:45–61
    1. Crane PK, Walker R, Hubbard RA, et al. Glucose levels and risk of dementia. N Engl J Med 2013;369:540–548
    1. Thambisetty M, Jeffrey Metter E, Yang A, et al. Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging. JAMA Neurol 2013;70:1167–1172
    1. Fliessbach K, Trautner P, Quesada CM, Elger CE, Weber B. Cerebellar contributions to episodic memory encoding as revealed by fMRI. Neuroimage 2007;35:1330–1337
    1. Filippini N, Ebmeier KP, MacIntosh BJ, et al. Differential effects of the apoE genotype on brain function across the lifespan. Neuroimage 2011;54:602–610
    1. Persson J, Lind J, Larsson A, et al. Altered deactivation in individuals with genetic risk for Alzheimer’s disease. Neuropsychologia 2008;46:1679–1687
    1. Seaquist ER, Chen W, Benedict LE, et al. Insulin reduces the BOLD response but is without effect on the VEP during presentation of a visual task in humans. J Cereb Blood Flow Metab 2007;27:154–160
    1. Friston KJ. Testing for anatomically specified regional effects. Hum Brain Mapp 1997;5:133–136

Source: PubMed

3
購読する